IPA Leadership
ENGINEERED for the Biotherapeutic Race
Hub of biotherapeutic intelligence

Dirk Van Hyfte MD PhD
Chief Technology Officer
Dirk Van Hyfte is the Chief Technology Officer of ImmunoPrecise Antibodies. With a degree in Medicine and specialization as a Psychiatrist from the prestigious University of Leuven in Belgium, Dirk's expertise extends beyond the realms of technology and business.
As a serial entrepreneur, Dirk has already made significant contributions to the field, with several of his groundbreaking ideas earning him patents. Notably, his remarkable achievement, iKnow, caught the attention of IT provider InterSystems, leading to its acquisition in 2010.
In addition to his entrepreneurial ventures, Dirk serves as a Bio-Medical Advisor, seamlessly blending his medical, AI-analytics, technological, and business acumen. He leverages his profound understanding of medical artificial intelligence, having obtained a PhD in the field from Nijmegen University in the Netherlands.
Dirk’s leadership brings a unique combination of healthcare systems knowledge and AI-driven strategy, positioning IPA at the forefront of industry innovation.